This study took LUAD as the research disease, focusing on the analysis of immunotherapy-related programmed death-ligand 1 (PD-L1, also called CD274) expression, tumor-infiltrating lymphocytes (TILs), and tumor microenvironment (TME) characteristics between Asians and Caucasians. Here, CD274 is linked to neoplasm.